Osnat Itzhaki Ben Zadok, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Amyloid Neuropathies, Familial | 6 | 2023 | 187 | 3.720 |
Why?
|
Heart-Assist Devices | 11 | 2023 | 1297 | 2.290 |
Why?
|
Cardiomyopathies | 7 | 2024 | 2068 | 1.930 |
Why?
|
Heart Failure | 19 | 2023 | 11837 | 1.880 |
Why?
|
Amyloidosis | 4 | 2024 | 883 | 1.780 |
Why?
|
Tricuspid Valve Insufficiency | 2 | 2022 | 363 | 1.030 |
Why?
|
Heart Transplantation | 6 | 2022 | 3310 | 0.830 |
Why?
|
Electric Countershock | 2 | 2024 | 536 | 0.770 |
Why?
|
Takotsubo Cardiomyopathy | 2 | 2021 | 127 | 0.740 |
Why?
|
Benzoxazoles | 1 | 2021 | 93 | 0.710 |
Why?
|
Takayasu Arteritis | 1 | 2021 | 106 | 0.690 |
Why?
|
Cardiac Valve Annuloplasty | 1 | 2018 | 52 | 0.600 |
Why?
|
Echocardiography, Transesophageal | 1 | 2024 | 1093 | 0.600 |
Why?
|
Endocarditis | 1 | 2022 | 349 | 0.580 |
Why?
|
Adrenergic beta-Antagonists | 2 | 2020 | 1238 | 0.570 |
Why?
|
Cardiovascular Agents | 1 | 2023 | 848 | 0.560 |
Why?
|
Rheumatic Heart Disease | 1 | 2018 | 164 | 0.560 |
Why?
|
Cardiac Resynchronization Therapy | 1 | 2023 | 562 | 0.540 |
Why?
|
Carpal Tunnel Syndrome | 1 | 2020 | 305 | 0.540 |
Why?
|
Angiotensin Receptor Antagonists | 2 | 2020 | 1060 | 0.530 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 2 | 2020 | 1513 | 0.530 |
Why?
|
Ventricular Dysfunction, Right | 1 | 2022 | 645 | 0.520 |
Why?
|
Israel | 6 | 2023 | 729 | 0.510 |
Why?
|
Tricuspid Valve | 1 | 2018 | 421 | 0.490 |
Why?
|
Prealbumin | 3 | 2023 | 264 | 0.490 |
Why?
|
Echocardiography | 7 | 2021 | 5040 | 0.480 |
Why?
|
Death, Sudden, Cardiac | 2 | 2023 | 1568 | 0.460 |
Why?
|
Defibrillators, Implantable | 1 | 2023 | 1497 | 0.420 |
Why?
|
Vascular Endothelial Growth Factor A | 2 | 2021 | 3498 | 0.420 |
Why?
|
Diabetes Mellitus | 3 | 2023 | 5889 | 0.380 |
Why?
|
Neoplasms | 6 | 2023 | 22340 | 0.370 |
Why?
|
Mitral Valve | 1 | 2018 | 1475 | 0.340 |
Why?
|
Patient Admission | 1 | 2017 | 1365 | 0.340 |
Why?
|
Forecasting | 1 | 2018 | 2936 | 0.320 |
Why?
|
Heart Diseases | 1 | 2022 | 2818 | 0.320 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 2018 | 1338 | 0.320 |
Why?
|
Mitral Valve Insufficiency | 1 | 2018 | 1415 | 0.310 |
Why?
|
Follow-Up Studies | 9 | 2021 | 39228 | 0.300 |
Why?
|
Stroke Volume | 3 | 2020 | 5595 | 0.290 |
Why?
|
Coronary Disease | 1 | 2021 | 5919 | 0.280 |
Why?
|
Humans | 46 | 2024 | 765926 | 0.280 |
Why?
|
Atrial Fibrillation | 3 | 2024 | 5186 | 0.270 |
Why?
|
Aortic Valve Stenosis | 1 | 2018 | 2022 | 0.260 |
Why?
|
Aged | 19 | 2024 | 171163 | 0.250 |
Why?
|
Retrospective Studies | 14 | 2023 | 81537 | 0.250 |
Why?
|
Adenocarcinoma | 1 | 2022 | 6360 | 0.230 |
Why?
|
Cardiac Surgical Procedures | 1 | 2019 | 3682 | 0.230 |
Why?
|
Survival Rate | 5 | 2021 | 12822 | 0.220 |
Why?
|
Female | 22 | 2024 | 396141 | 0.210 |
Why?
|
Blood Glucose | 1 | 2017 | 6422 | 0.200 |
Why?
|
Treatment Outcome | 9 | 2023 | 65194 | 0.200 |
Why?
|
Vaccines, Synthetic | 2 | 2022 | 622 | 0.200 |
Why?
|
Prognosis | 6 | 2022 | 29890 | 0.190 |
Why?
|
Benzazepines | 1 | 2023 | 308 | 0.190 |
Why?
|
Middle Aged | 16 | 2024 | 223016 | 0.190 |
Why?
|
Heart | 3 | 2023 | 4419 | 0.180 |
Why?
|
Aged, 80 and over | 7 | 2021 | 59496 | 0.180 |
Why?
|
Postoperative Complications | 2 | 2019 | 15802 | 0.170 |
Why?
|
Ventricular Function, Left | 4 | 2021 | 3930 | 0.170 |
Why?
|
Risk Assessment | 2 | 2019 | 24275 | 0.170 |
Why?
|
Heparin, Low-Molecular-Weight | 1 | 2022 | 344 | 0.170 |
Why?
|
Antibodies, Viral | 2 | 2022 | 3213 | 0.170 |
Why?
|
Cardiology | 2 | 2021 | 1696 | 0.170 |
Why?
|
Male | 19 | 2024 | 363815 | 0.170 |
Why?
|
Immunization, Secondary | 1 | 2022 | 373 | 0.170 |
Why?
|
Acute Coronary Syndrome | 2 | 2023 | 2185 | 0.160 |
Why?
|
Heart Function Tests | 1 | 2020 | 317 | 0.160 |
Why?
|
Fibrin | 1 | 2022 | 514 | 0.160 |
Why?
|
Myocardial Infarction | 2 | 2021 | 11508 | 0.160 |
Why?
|
Mucins | 1 | 2022 | 568 | 0.160 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 1 | 2021 | 548 | 0.150 |
Why?
|
Radionuclide Imaging | 1 | 2023 | 1985 | 0.150 |
Why?
|
Time Factors | 5 | 2020 | 40097 | 0.150 |
Why?
|
Cardiovascular Diseases | 2 | 2021 | 15645 | 0.150 |
Why?
|
Heart Ventricles | 2 | 2021 | 3833 | 0.140 |
Why?
|
Prospective Studies | 6 | 2022 | 54807 | 0.140 |
Why?
|
Coronary Artery Disease | 3 | 2022 | 6544 | 0.130 |
Why?
|
Anticoagulants | 3 | 2022 | 4856 | 0.130 |
Why?
|
Stroke | 1 | 2018 | 9739 | 0.130 |
Why?
|
Primary Prevention | 1 | 2023 | 1187 | 0.120 |
Why?
|
Antithrombins | 1 | 2018 | 295 | 0.120 |
Why?
|
Sex Factors | 2 | 2019 | 10611 | 0.120 |
Why?
|
Registries | 3 | 2022 | 8346 | 0.120 |
Why?
|
Myocarditis | 1 | 2022 | 803 | 0.120 |
Why?
|
Anemia, Iron-Deficiency | 1 | 2019 | 374 | 0.120 |
Why?
|
Disease Progression | 2 | 2023 | 13614 | 0.110 |
Why?
|
Cohort Studies | 3 | 2022 | 41680 | 0.110 |
Why?
|
Rare Diseases | 1 | 2019 | 629 | 0.110 |
Why?
|
Comorbidity | 2 | 2019 | 10575 | 0.110 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2018 | 878 | 0.110 |
Why?
|
Disease Susceptibility | 1 | 2020 | 1787 | 0.110 |
Why?
|
Consensus | 1 | 2023 | 3202 | 0.100 |
Why?
|
Heart Rate | 1 | 2023 | 4203 | 0.100 |
Why?
|
Chest Pain | 1 | 2019 | 1102 | 0.100 |
Why?
|
Coronary Angiography | 2 | 2021 | 4498 | 0.090 |
Why?
|
Cholesterol, LDL | 1 | 2021 | 2395 | 0.090 |
Why?
|
Iron | 1 | 2019 | 1811 | 0.090 |
Why?
|
Coronary Vessels | 1 | 2021 | 3094 | 0.090 |
Why?
|
Flow Cytometry | 1 | 2021 | 5880 | 0.090 |
Why?
|
Myocardium | 1 | 2023 | 4764 | 0.080 |
Why?
|
Hemorrhage | 2 | 2021 | 3466 | 0.080 |
Why?
|
Disease Management | 1 | 2020 | 2530 | 0.080 |
Why?
|
Hypertension | 2 | 2021 | 8616 | 0.080 |
Why?
|
Guideline Adherence | 1 | 2019 | 2234 | 0.080 |
Why?
|
Combined Modality Therapy | 1 | 2020 | 8522 | 0.070 |
Why?
|
Hospitalization | 2 | 2019 | 10810 | 0.070 |
Why?
|
Reoperation | 1 | 2018 | 4308 | 0.070 |
Why?
|
Health Personnel | 4 | 2021 | 3385 | 0.070 |
Why?
|
Tissue Donors | 3 | 2021 | 2392 | 0.070 |
Why?
|
Risk Factors | 5 | 2023 | 74850 | 0.070 |
Why?
|
Electrocardiography | 1 | 2019 | 6409 | 0.070 |
Why?
|
Health Status | 1 | 2019 | 4085 | 0.060 |
Why?
|
RNA, Messenger | 1 | 2021 | 12768 | 0.060 |
Why?
|
Thrombosis | 1 | 2019 | 2955 | 0.060 |
Why?
|
Diagnosis, Differential | 1 | 2019 | 12973 | 0.060 |
Why?
|
Hospital Mortality | 1 | 2017 | 5339 | 0.050 |
Why?
|
Age Factors | 1 | 2019 | 18382 | 0.050 |
Why?
|
Body Mass Index | 1 | 2020 | 13042 | 0.050 |
Why?
|
Adult | 4 | 2021 | 223088 | 0.050 |
Why?
|
Phenotype | 1 | 2020 | 16714 | 0.050 |
Why?
|
Quality of Life | 1 | 2021 | 13463 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2023 | 12235 | 0.040 |
Why?
|
Tacrolimus | 1 | 2022 | 754 | 0.040 |
Why?
|
Thrombin | 1 | 2021 | 601 | 0.040 |
Why?
|
Erythrocyte Indices | 1 | 2019 | 144 | 0.040 |
Why?
|
Hospitals | 2 | 2021 | 3886 | 0.040 |
Why?
|
Self Care | 1 | 2023 | 800 | 0.040 |
Why?
|
Meta-Analysis as Topic | 1 | 2019 | 1366 | 0.030 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2022 | 2057 | 0.030 |
Why?
|
Oxygen Consumption | 1 | 2019 | 1872 | 0.030 |
Why?
|
Quality-Adjusted Life Years | 1 | 2019 | 1740 | 0.020 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2020 | 1735 | 0.020 |
Why?
|
Women's Health | 1 | 2021 | 2081 | 0.020 |
Why?
|
ROC Curve | 1 | 2019 | 3612 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2021 | 6306 | 0.020 |
Why?
|
Hypoglycemic Agents | 1 | 2023 | 3106 | 0.020 |
Why?
|
Immunoglobulin G | 1 | 2022 | 4555 | 0.020 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2021 | 2769 | 0.020 |
Why?
|
Patient Discharge | 1 | 2021 | 3460 | 0.020 |
Why?
|
Cause of Death | 1 | 2019 | 3715 | 0.020 |
Why?
|
Peptide Fragments | 1 | 2020 | 5126 | 0.020 |
Why?
|
Early Detection of Cancer | 1 | 2020 | 3238 | 0.020 |
Why?
|
Incidence | 1 | 2023 | 21513 | 0.010 |
Why?
|
Pandemics | 1 | 2023 | 8721 | 0.010 |
Why?
|
Emergency Service, Hospital | 1 | 2021 | 7871 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2023 | 26282 | 0.010 |
Why?
|
Pregnancy | 1 | 2021 | 30230 | 0.010 |
Why?
|
Young Adult | 1 | 2019 | 59857 | 0.010 |
Why?
|
Adolescent | 1 | 2019 | 88811 | 0.010 |
Why?
|